Caplight Directory>Companies>EV Therapeutics-preview>Evtherapeutics


EV Therapeutics

EV Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.evtherapeutics.com/

Last Round

Accelerator

Sep 20, 2023

Company Overview

EV Therapeutics is a biotechnology company developing off-the-shelf neoantigen-based immunotherapies from tumor-derived extracellular vesicles to treat advanced-stage cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

immuno-oncologycancer vaccineextracellular vesiclestherapeutic cancer vaccinecancer immunotherapymTEVscolorectal cancerexosome therapyneoantigen deliverycheckpoint inhibitor resistanceI-Opre-clinical biotechMSS colorectal cancerdrug discovery platformbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EV Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EV Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 20, 2023
AngelJul 1, 2020
View all Funding Rounds

Key People

Founding team and executive leadership

SUBREE SUBRAMANIAN

Chief Scientific Officer And Co-founder

Founding Team

EV Therapeutics Investors

Notable investors and investment history

InvestorRounds
University of MinnesotaAngel
California Life SciencesAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors grew 96% MoM.

  • Jun 1, 2025

    Monthly visitors grew 520% MoM, from 153 to 948.

View all signals

EV Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EV Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EV Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2020
Last FundingSep 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.